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ABSTRACT 
Aims: To identify RCTs in which Diabetes Distress was assessed in adults under experimental 
conditions and to undertake meta-analysis of intervention components to determine effective 
interventions for reducing Diabetes Distress.  
Methods: Systematic review searching Medline, Psychinfo and Embase to March 2013 for studies 
measuring Diabetes Distress. Two reviewers assessed citations and full papers for eligibility based 
on RCT design and PAID or Diabetes Distress Scale outcome measure. Interventions were 
categorised by content and medium of delivery. Meta-analyses were undertaken by intervention 
category where ≥7 studies were available. Standardised mean differences and 95% confidence 
intervals were computed and combined in a random effects meta-analysis.  
Results: Of 16,627 citations reviewed, 41 RCTs involving 6,650 participants were included. 
Twenty one apriori meta-analyses were undertaken. Effective interventions were psycho-education 
[-0.21 [-0.33, -0.09]], generalist interventionist [-0.19 [-0.31, -0.08]], ≥6 sessions [-0.14 [-0.26, -
0.03]] and ≥3 months duration [-0.14 [-0.24, -0.03]]. Motivational interviewing reduced diabetes 
distress [-0.09 [-0.18, -0.00]] and improved baseline elevated glycaemia [-0.16 [-0.28, -0.04]]. 
Although statistical significance was observed most effect sizes were below 0.2.  
Conclusion: The review signposts interventions likely to reduce elevated Diabetes Distress in type 
1 and 2 and across the age profile. Interventional research is needed and warranted targeting 
elevated distress.   
INTRODUCTION 
Living with diabetes carries with it an emotional burden with depression, anxiety and eating 
disorders being amongst the most widely researched (1). A state of distress associated solely with 
living with diabetes, Diabetes Distress, has developed prominence in the literature over the last 
decade (2-7)  particularly in type 2 populations, although its measurement has been possible since 
the publication of the Problem Areas in Diabetes Scale (PAID) in 1995 (8). The PAID scale has 
been widely validated and used in research studies (3-7). It has 20 items and scores on a 0-100 
scale. A PAID score of ≥40 is widely accepted to indicate elevated distress (5,9), which is one 
standard deviation above the mean for patients with diabetes (10). More recently the Diabetes 
Distress Scale (DDS) has been published with some of the same authors with 17 items a 0-4 
response scale and a threshold for distress of 2.5 (11). Diabetes Distress (DD) is characterised by 
emotional distress in relation to diabetes and its management and has four domains (or sub-
scales) of emotional burden, regimen-related distress, diabetes-related interpersonal distress and 
physician-related distress (11). These four sub-scale domains have reliability and validity and have 
been employed in research (12, 13). 
 
For people with elevated DD, self-management and the control of glycaemia is a substantial 
emotional burden. In the UK, 81% of primary care patients with type 2 report ‘some degree’ of DD 
[14] and the point prevalence in the community of significant DD is 18%, which increases to almost 
30% when any presentation over an 18 month period was considered [2]. In type 1, Byrne et al 
(2012) reported 39% of their study population to have elevated DD (15). The emotional problems 
most frequently endorsed by people with diabetes relate to worry about high blood sugar, 
hypoglycemia and the risk of future complications [2-6,10] and feeling guilty when getting off track 
with self-management [3-5, 7,8,14]. Crucially, recent work has indicated that only DD 
demonstrates an independent concurrent association with HbA1c and a time concordant 
association in which fluctuations in DD correspond with changes in HbA1c over time [16, 17]. The 
average reduction in DD corresponds with a clinically significant reduction in HbA1c [18, 19]. That 
DD interferes with self-care in diabetes is supported by clinical observation of one of the authors 
(20) although longitudinal evidence is conflicting in this association (17, 21).  Evidence has 
demonstrated a strong association between depression and DD [6, 7]. However, some research 
has reported that it is depressive symptom severity, rather than major depressive disorder, with 
which DD is principally related [7, 16]. Recent literature has suggested that DD is more prevalent 
than major depressive disorder in diabetes [2] which has prompted calls for intervention endeavors 
to shift from those solely for depression towards targeting DD as a means of improving well-being 
but also potentially facilitating change in self-management behaviours and important clinical 
outcomes in diabetes [22,23]. 
 
Interventions specifically targeting DD are greatly understudied offering little to inform clinicians 
how to intervene to reduce DD. Diabetes Distress has been regularly assessed as a secondary 
outcome in experimental studies [24-28] and these studies may collectively indicate intervention 
components, not originally designed to target DD, which did so nonetheless. The objective of this 
paper is to identify experimental studies in which DD was reduced following experimental 
intervention and to identify the intervention components and characteristics that resulted in 
clinically significant effect sizes.  
 
METHODS 
A systematic review of randomised controlled trials was undertaken using the Preferred Reporting 
Items for Systematic Reviews and Meta-analyses [PRISMA] guidelines [29]. Population was any 
adult population with diagnosed type 1 or 2 diabetes, where DD was assessed, irrespective of the 
intervention focus and the primary outcome.  
 
Data sources and searches 
A review of outcome measures assessing DD was undertaken at the outset [30] which resulted in 
the identification of a small number of outcome measures to assess DD. Because several 
measures were not widely used and/or fully validated, we only included studies which had used the 
full Problem Area in Diabetes Scale [PAID] [8] or the Diabetes Distress scale [DDS] [11]. Medline, 
Psychinfo and Embase databases were searched from 1995 to March 2013 for relevant citations 
with no language restrictions.  The search strategy (available from the authors) was designed to 
capture the different terms attributed to the person’s experience of diabetes tapped into by these 
measures of DD, for example stress, quality of life, diabetes problems, diabetes emotions. Each 
citation was assessed by two investigators. We did not employ RCT filters because we were 
interested in capturing all studies measuring DD. This paper reports only those studies that we 
identified as RCTs during citation and abstract assessments. All citations/abstracts were assessed 
for inclusion by two researchers. 
 
Data extraction and quality assessment 
Data were extracted by one investigator and quality checked by a second on population and 
setting, sample size, follow up points, DD measure, outcome data for DD and glycaemic control,  
experimental and comparison intervention characteristics, including, use of theory, content, 
medium of delivery, interventionist, focus and intensity. No investigator extracted data from their 
own included study. Authors were contacted once to request missing outcome data. Where 
multiple arms were reported, the intervention identified by authors as the most and least active was 
included. Where studies were reported in more than one paper, they were collated such that the 
unit of interest was at the study rather than publication level. Studies were excluded from meta-
analysis if mixed diabetes populations could not be separated in the results or trials were of 
equivalence design. We used the Cochrane Collaboration tool for assessing risk of bias (31) to 
assess for high, unclear or low risk of bias in the adequacy of reporting of sequence generation, 
allocation sequence concealment, blinding of outcome assessors and outcome data. Assessments 
were undertaken on all included studies by one author and a 10% sample independently assessed 
by a second author.  
 
Data synthesis and analysis 
Once intervention data were extracted, we built category descriptors (table 1) and these categories 
formed the basis of our meta-analyses. This resulted in 6 intervention categories and 40 
components. Meta-analysis was undertaken where ≥ 7 studies were available for each analysis 
enabling 21 meta-analyses including 3 main categories, 3 medium of intervention delivery and 15 
analyses of potentially important intervention components effecting DD outcome. The PAID and 
the DDS were developed by some of the same investigators and, in their respective theoretical 
justifications and at the item level, similarities between the scales are discernable.  Sub group 
analysis based on outcome measure was not possible owing to insufficient distribution of studies 
across the subgroups so in view of aforementioned context we conducted the analysis on the 
combined data set. Diabetes Distress and HbA1c is reported as continuous data, therefore the 
mean and standard deviation at baseline and follow-up were extracted for each intervention and 
each outcome. Standardised difference in means [SMDs] and 95% confidence intervals [95% CIs] 
were then computed based on the endpoint diabetes distress data for each study. Some 
heterogeneity was anticipated and SMDs were combined in a random effects meta-analysis. Effect 
heterogeneity was assessed by visual inspection of forest plots and statistical test; Chi-squared 
[X2], and quantified using the I² index [32]. Percentages of 25%, 50% and 75% indicate low, 
medium and high heterogeneity respectively. Risk of publication bias was assessed by visual 
inspection of funnel symmetry in the plots of each trial's SMD against its SE [i.e. funnel plot].  Effect 
sizes of 0.2, 0.5 and 0.8 are conventionally interpreted as small, medium and large, respectively 
[33,34]. An effect size of 0.15 was considered clinically important because it would be expected 
that 6% of the diabetes population would do better than by chance alone [i.e. U3=.56].  
 
Table 1 Construction of apriori intervention categories 
 
RESULTS 
Study selection 
The search revealed 16,627citations, 1,077 full text papers were retrieved and 298 papers 
representing 188 unique studies were reviewed [Fig 1]. The reason for study exclusion in the 
majority of cases was because they did not measure DD. Forty one RCTs were included for which 
full DD outcome data were obtainable involving 6,650 participants. Six authors provided missing 
data.  
Figure 1. Flowchart of included studies 
 Study and participant characteristics 
Studies were undertaken in 11 countries with 17 undertaken in USA (Tab 2). Diabetes Distress was 
measured by the PAID in 35 studies and the DDS in 6. Glycemic control was also assessed in 34 
studies and depression in 22. Mean participant characteristics were male 47%, mean age 56.5yrs. 
Ethnicity was reported in 21 studies of which 5 involved a majority of ethnic minority populations, 
one exclusively Caucasian participants with the remaining 15 having between 1.5-45% of ethnic 
minority participants.  Community settings were represented in 16 studies and hospital diabetes 
clinics in 14 studies. Type 2 diabetes was the sole or majority population in 34 studies. 1,133 type 1 
participants [17% of all review participants] were represented in 8 studies. In 16 studies over 20% of 
participants were treated with Insulin. Mean DD at baseline ranged from 14.5 – 60 in the 35 studies 
using the PAID. Mean DD was at, or above, threshold in only seven studies. Mean HbA1c was above 
7.5% [58.5 mmol/mol] in 28 studies.  
 
Table 2 Characteristics of included studies 
 
Meta-analysis 
The 41 studies contained a wide range of heterogeneous interventions and consequently meta-
analysis did not indicate an intervention effect on DD outcome [-0.06 [-0.13, 0.01]. Eleven of the 
included studies individually found in favor of the comparison arm. Meta-analysis findings by 
Intervention category and component are detailed in table 3. 
Content categories: Psycho-education was the only content category which significantly reduced 
DD compared to controls [Fig 2]. Psychological, DSME, and Care/Case management categories 
did not significantly improve DD. There were only three studies in the Drugs/Devices category and 
on individual inspection of the outcomes, DD was found to be higher in the experimental arm at 
follow up [SMD 0.03 [-0.18, 0.24] & 0.51 [0.12, 0.89] respectively]. 
Medium of delivery categories: The format of delivery categories, involving combinations of face to 
face, remotely delivered and technologically delivered content, did not significantly influence DD 
outcomes.  
Potentially important components: Interventions delivered by generalist clinicians located in 
primary care resulted in significant DD reductions. Interventions delivered by diabetes specialists, 
typically working in hospital settings, were not associated with significant reductions [SMD -0.06 [-
0.13, 0.01]]. Observation of 5 of the 6 psychologist delivered interventions indicated that the 
psychologist as interventionist reduced DD significantly relative to control interventionists. Neither 
group vs. individual formats, the clinical focus of the intervention [E.G. mood, weight loss, glycemic 
control] nor the presence/absence of theory in driving the intervention effected DD outcome. 
Intervention intensity of ≥ 6 intervention sessions and duration of ≥ 13 weeks reduced DD 
compared to controls. Less intensive interventions did not significantly reduce DD. Twenty eight 
studies had mean baseline HbA1c over 7.5% [58.5 mmol/mol] seven of which offered Motivational 
Interviewing (population n= 1673). In these seven studies we observed reductions in HbA1c and 
significant reductions in DD (-0.16 [-0.28, -0.04]. Similar borderline reductions in DD and HbA1c 
were observed in 11 interventions which had ≥ 6 sessions, (population n=1673) (-0.13 [-0.23 -, 
0.04]). Although statistical significance was observed, as noted in table 3, many of these effect 
sizes were below 0.15 [33, 34]. 
 
Figure 2. Forest Plots of intervention effects 
 
Table 3. Apriori sub-group analyses for components associated with reduced Diabetes 
Distress 
 
Sensitivity analysis and study bias 
Sensitivity analyses were undertaken to asses impact of removal of type 1 and mixed sample 
studies and these were negligible and did not change the overall result of meta-analysis. Risk of 
bias assessments demonstrated methodological flaws in many of the included studies. Twenty four 
studies had a high risk of bias, 13 a moderate risk, 3 a low risk, and 1 study in which data was 
provided by the author was unable to be assessed.  The presence of small and non-significant 
studies suggest that publication bias was unlikely. Risk of bias data is available from the authors. 
 
DISCUSSION 
Our review revealed a considerable number of research studies that have measured Diabetes 
Distress indicating that researchers, clinicians and people with diabetes regard this as an important 
diabetes phenomenon. Psycho-education involving diabetes and mood or motivation content, 
delivered in any format, was significantly associated with reduced distress at follow up. Intervention 
delivery components which reduced DD involved general clinicians and were of both greater intensity 
and duration. Intensity of intervention and Motivational Interviewing components were found to 
significantly reduce both DD and HbA1c.  
 
Psychological problems usually require psychological solutions [35, 36]. Diabetes Distress however 
appears to respond to psycho-education and affords the diabetes as well as the emotion a central 
therapeutic position. This might be explained in relation to improvements in diabetes management 
self-efficacy as there are several included studies that identify reductions in DD alongside 
improvements in self-efficacy [s2; s9; s11; s22]. People develop mastery in relation to their diabetes 
management through knowledge and skill acquisition derived from the diabetes content alongside 
communication, reflection and motivational insights derived from the psychological components. 
This may enable them to experience a level of control that reduces their sense of helplessness in 
relation to this complex condition. Continuity and access offered by primary care may explain the 
significance of the generalist clinician. This finding may arise from the predominance of type 2 
studies, reflecting the importance of care close to home facilitating easy access to care, continuity 
of care and carer and the pastoral elements of general practice relationships. If access and continuity 
are important for all people with diabetes then it indicates that these outcomes may need to be a 
focus of interventions to reduce DD, rather than the generalist clinician per sae. This is somewhat 
contradicted by our finding that combined face to face and remotely delivered interventions, which 
would facilitate access and continuity, did not appear to influence DD outcome and reinforces the 
finding that generalists are important. 
 Motivational interviewing has been widely evaluated to determine its effectiveness in promoting 
patient self-management across a range of long term conditions [37, 38]. With the exception of trials 
in diabetes in which findings have been equivocal [39, 40], Motivational Interviewing has been widely 
considered effective in changing health related behaviours. Motivational Interviewing trials in long 
term conditions have assessed its effectiveness based on patient reported outcome measures 
[PROM] whereas diabetes trials have largely focused on evaluating change in glycemic control, a 
complex biological variable. In our study Motivational Interviewing was assessed using the PAID and 
the DDS which are PROMs and was found to reduce DD. In trials where this resulted, Motivational 
Interviewing also reduced elevated HbA1c.This effect was of borderline significance, however so it 
remains unclear whether it reduces DD, despite reducing HbA1c. Nonetheless, the association 
between DD and glycaemia in these 7 Motivational Interviewing trials is notable and requires further 
research attention. 
 
As noted, DD was not influenced by face to face or remote delivery nor by group or 1:1 interactions. 
There is clinical interest currently in digital clinical communications by email, text, mobile and web 
portals [41,42] with a rational that they can improve access to health care and therefore might be 
expected to reduce distress. Our analysis did not find evidence for this. Face to face consultations, 
solely or in addition to remote access via telephone or digital methods, remained the most frequently 
delivered experimental intervention. Two of the three included Drugs/Devices interventions, a trial of 
insulin intensification (s5) and in another of blood glucose monitoring (s37), found DD to be higher 
in the experimental arm at follow up raising concerns that drug and device intensification can 
increase DD. As diabetes care becomes increasingly technological around blood glucose 
monitoring, insulin delivery systems, new drugs, dose titration and web applications to record and 
analyse the data it is of concern to companies and clinicians that these innovations do not increase 
DD. The impact of new drugs/doses on health related quality of life is now a major feature of many 
drug trials [43] and DD may have a place alongside in understanding the diabetes burden associated 
with innovations in treatments and care. 
 
This is the first review to be undertaken of the published DD literature using a comprehensive search 
strategy and PRISMA methods [29] resulting in the analysis of a large number of trials with statistical 
and clinical homogeneity. Ethnicity was reported in half of the included trials and representation of 
ethnic minority populations in the studies indicates that the meta-analyses broadly represents a 
diverse population with diabetes. The analysis process of developing intervention categories, from 
collections of components which could support meta-analyses, was thorough and transparent. The 
findings enable acceleration of experimental research targeting DD. There are a number of review 
limitations. DD has been variously described over 2 decades and only 3 databases were searched 
and it is inevitable that some studies will have been missed. In multiple arm trials 
(s10,s14,s15,s25,s33,s34,s37,s38,s41), we recognise limitations in selecting the most and least 
active intervention arms to address the issue of non-independence of effects from an individual study 
contributing to the meta-analysis. Cochrane advocates that a preferable approach is to define 
intervention and comparison arms and combine data within these newly formed groups. In the 
instance of RCT estimating treatment effects of complex interventions such an approach is 
inappropriate in view of the complex heterogeneity even between the different intervention and 
control arms within a single study. In effect, the unique effects of differing interventions are averaged 
out such that the overall estimate does not reflect something meaningful. After careful consideration 
of alternative approaches offered within the Cochrane handbook (44) we felt our approach to be the 
most appropriate means of approximating the truth. Twenty four of our 41 included studies were 
assessed as having a high risk of bias. Removing these studies to undertake sensitivity analyses 
would have made meta-analyses by intervention category/component not possible. This many 
studies with a high risk of bias means that some caution is required in interpreting the results. Most 
effect sizes were lower than 0.2 conventionally regarded as small by Cohen's D [26,27]. The mean 
DD levels of participants in the trials were below threshold and the next research steps are to develop 
trials to determine effect sizes when these intervention components are targeted at people with 
elevated DD at baseline.   
 
 
 
Implications for research and practice 
Theory and clinical hunch have thus far been the only guidance available to clinicians and 
researchers in developing interventions to reduce Diabetes Distress. This review is signposting 
psycho-educational interventions with diabetes and mood/motivation content, delivered more 
intensively and emphasising access and continuity of care. Many psycho-educational interventions 
with one or more of these content elements are revealed in our review [s16; s21; s23; s25; s27; s28; 
s30; s32; s38; s40]. Motivational Interviewing may offer more opportunity in diabetes than thought 
previously. These now need evaluating in type 1 and type 2 populations with elevated distress in 
experimental conditions with DD distress as the primary outcome.  
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Table 1 Construction of apriori intervention categories  
 
 
Intervention 
components   
Possible intervention components  
Intervention Content 
 (11 components) 
CBT; Psychotherapeutic techniques; Supportive counselling; Problem 
solving; Goal setting/action planning/ solution focused; Motivational 
consultation; Care planning; Education; Writing intervention; Self-help 
(bibliotherapy); Drugs and Devices;  
Medium of delivery 
(12 components) 
Telephone support; Online with person support; Online with computer 
generated support; Text messaging; Audio/visual aids (i.e. CD/DVDs); 
written materials; health professional involved; peer involved; group; 
individual; number of sessions; duration of intervention;  
Focus of intervention 
(12 components) 
Diabetes Distress; Other mood/ emotions management; Weight loss; 
Physical activity; Medication adherence (tablets or insulin); Blood 
glucose control; Increase knowledge; Behaviour change (in general); 
Appointment attendance; Carbohydrate counting; Dietary control; Blood 
glucose monitoring;  
Interventionist 
(5 components) 
Generalist (GP/practice nurse); Diabetes specialist (nurse; dietician); 
Psychological specialist; Lay person with diabetes; Multi-disciplinary (2 
or more different disciplines);  
Stage 2- Building 
intervention 
categories from 
component detail 
Intervention 
Category title (used 
in meta-analyses) 
Criteria 
Cognitive behaviouiral 
techniques/therapy;  
Motivational 
interviewing incl MI 
techniques;  
Supportive counselling 
Psychotherapy 
 
 
Psychological  
MI was only included if the MI body of work 
was referenced in the methods section AND 
there was detail about which MI techniques were 
used.  
Where supportive counselling was the 
psychological intervention; a minimum of one 
technique must be identified in the interventional 
description reflection; supportive listening.  
Goal setting and problem solving content; in the 
absence of education but alongside CBT; MI; 
Supportive Counselling or Psychotherapy; was 
categorised as Psychological. 
Education in any 
format group; 1:1; 
online; face to face plus 
a psychological 
intervention as 
described in 
Psychological category 
 
Psycho-educational 
The educational component could be diabetes or 
mental health related (e.g depression patient 
education) delivered by health professional or 
peer. 
These interventions required 1) an educational 
currululum; 2) a diabetes or mental health 
learning opportunity AND 3) either a 
motivational OR affect component. 
Education in any 
format group; 1:1; 
online; face to face 
Educational No behavioural or skill development elements; 
purely information about diabetes or a mental 
health condition. 
Education as described 
in Educational 
category plus goal 
setting/ planning/ 
solution focussed/ 
problem solving 
components 
Diabetes self-
management 
education (DSME) 
These interventions had NO psychologically 
therapeutic components. 
 
 
Drug- Insulin titration 
or anti-depressant 
commencement  
Devices – Continuous 
Blood Glucose 
Monitoring or Insulin 
Pumps 
 
Drugs & Devices Category contains diverse and small number of 
studies that are less complex (fewer components) 
and more heterogeneous.  
Care management and 
case management 
Care/case 
management 
These were interventions focussing on detecting 
people with the condition of interest (diabetes or 
diabetes and depression) at either the individual 
(case) or the cohort level (care) level and 
delivering an intervention protocol (care 
planning) focussed on referral, medication,  
investigation and follow up.  
 
MI Motivational Interviewing; CBT Cognitive Behaviour Therapy; 1:1 one to one 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2. Characteristics of included studies 
 
 
 
 
 
 
MAIN PAPER 
& 
PUBLICATIO
N DATE 
[OTHER 
PAPERS] 
LOCATION  
 
 
 
 
 
STUDY 
DESIGN/DD 
OUTCOME 
MEASURES/ 
LONGEST 
FOLLOW UP  
 
 
 
 
 
POPULATION AND 
SETTING 
SAMPLE [I/C], 
GENDER, AGE, TI/T2 
%, SETTING, 
INSULIN % 
 
 
 
 
 
INTERVENTION AND 
COMPARISON GROUP 
USED IN META-ANALYSIS 
 
 
 
 
 
MEAN B’LINE DATA 
FOR DD AND HBA1C 
 
 
 
 
 
OTHER ASSESSED OUTCOMES;  
WAS PRIMARY OUTCOME [P] IN FAVOUR 
OF INTERVENTION? 
SIMSON 2008 
GERMANY 
[S1] 
RCT; PAID; End 
of treatment 
[discharge] 
30 [15/15], male 57%, 
mean 61yrs, T1 
[77%]/T2 [23%], 
hospital inpatients, 
21% Insulin 
Psychological; theory 
based Psychotherapy with 
mood focus. Individual face 
to face delivered by Psych 
specialist; 5 x 30 min 
sessions over 6 weeks Vs 
Usual Care                   
DD I 34.6 [9.4] C 30.9 
[17.2]: HbA1c I 7.8% 
[SD1.5] [62mmol/mol] C 
8.7% [SD1.8] 
[72mmol/mol] 
Depressive symptoms [P], anxiety symptoms 
Yes 
VAN DER 
WULP 2012 
NETHERLAN
D 
[S2] 
RCT; PAID; 6 
mth 
133 [68/65], males 
55%, mean age 61yrs, 
T2, Primary care, 
Insulin 3% 
Psychological; theory 
based individual Motivational 
Interviewing and goal 
oriented lifestyle focus. Peer 
face to face and telephone 
delivered. 6 individual 60 min 
contacts over 3 mths Vs 
Usual care 
DD I 16.65 [18.95] C 
14.48 [15.50]  
Self-efficacy [P], depressive symptoms, 
psychological well-being, coping, physical 
activity, dietary habits 
Yes 
SHIBAYAMA 
2007  
JAPAN 
[S3] 
RCT; PAID; 
12mth 
134 [67/67], male 65%, 
mean 62 yrs, T2, 
hospital clinic. 0% 
Insulin   
Psychological; theory 
based, supportive 
counselling/goal oriented 
with behaviour change 
focus. Face to face with 
written materials. Diabetes 
specialist individually 
delivered monthly x 25 mins 
[mean] for 12 mths Vs Usual 
care 
DD I 40.2 [14.3] C 38.9 
[15.9]: HbA1c I 7.3% [56 
mmol/mol] C 7.4% [57 
mmol/mol] 
HbA1c, health-related quality of life, CVD 
outcomes 
Primary NR.  
ROSENBEK 
MINET 2011 
DENMARK 
[S4] 
RCT; PAID; 
24mths 
349 [173/176],males 
50%,  Mean age 
56.4yrs, T1 [22%]/T2 
[78%], hospital clinic, 
38% Insulin 
Psychological; theory 
based Motivational and goal 
oriented with behaviour 
change focus. Individually 
delivered face to face by 
DD I 20 [17.7] C 19.6 
[16.3]: HbA1c I 7.0% [53 
mmol/mol] C 
7.0% [53mmol/ mol] 
HbA1c [P], self-efficacy, CVD outcomes 
No 
multi-disciplinary team. 5 x 
35 min sessions over 12 
mths Vs Usual care 
VAN DEN 
DONK 2010 
NETHERLAN
D 
[S5] 
RCT; PAID; 54 
mths 
498 [255/243], age & 
gender not reported, 
T2, screening 
programme, Insulin NR 
Drug/Devices; Theory NR. 
Drug Intensification and 
education delivered 
individually & face to face by 
diabetes specialist. No of 
sessions NR duration over 3-
4 yrs Vs Usual care 
NR Health status, treatment satisfaction 
Primary NR 
RYGG 2012  
NORWAY 
[S6] 
RCT; PAID; 12 
mths 
146 [73/73], male 55%, 
mean 66yrs, T2, 
General Practice, 18% 
Insulin 
DSME; Theory NR. Group 
education and problem 
solving, no theory reported. 
Face to face delivered by 
MDT and peers with a 
behaviour change focus. 3 x 
5 hr sessions over 1.5 weeks 
Vs Wait list control 
DD: I 22.1 [16.4] C 18.2 
[16.2]: HbA1c I 7.1% [SD 
1.4] [54 mmol/ mol] C 
6.9% [SD 1.3] [52mmol/ 
mol] 
HbA1c [P], patient activation [P],  treatment 
satisfaction,   
knowledge, self-management, global health, 
health-related QOL, CVD outcomes, health 
care utilization 
No 
SIGURDARD
OTTIR 2009 
ICELAND 
[S7]   
RCT; PAID; 6 
mths 
53 [30/28], male 51%, 
mean age 60.5yrs 
[10.5], T2, general 
practice and hospital 
clinics, 25% Insulin 
DSME: theory based 
education, problem solving 
and goal oriented, face to 
face and telephone, 
individually delivered by 
diabetes specialist. 1  x 2 hr 
face to face and 5 telephone 
contacts over 6 weeks Vs 
Usual care 
DD I 24.1 [14.5] C 15.8 
[14.5]: HbA1c I 8.1% [SD 
0.95] [65 mmol/ mol] C 
7.88% [SD 0.89] [63 
mmol/ mol] 
HbA1c [P], well-being, empowerment,  
self-management, BMI, waist circumference 
No 
ZOFFMANN 
2006  
DENMARK 
[S8] 
RCT; PAID; 
12mths 
61 [36/25], male 48%, 
mean 36.3yrs, T1, 
hospital clinic, 100% 
Insulin 
DSME: theory based 
education, self-directed 
materials, goal oriented with 
empowerment focus. Group 
& individual face to face by 
diabetes educator. 7 x 2 hr 
sessions over 8 weeks Vs 
Waiting list control 
DD I 32 [3.4] C 40.9 [4]: 
HbA1c I 9.01% [SD 0.02] 
[75 mmol/ mol] C 9.05% 
[SD 0.2] [75 mmol/ mol] 
  
  
HbA1c, autonomy support, treatment self-
regulation, frequency of self-monitored blood 
glucoses, perceived  
competence in managing diabetes 
Primary NR 
ANDERSON 
2009   
USA [S9] 
RCT; PAID; 24 
mths 
310 [156/154], male 
41%, mean 56yrs, T2, 
Primary care, Insulin 
27% 
DSME: Theory based, Goal 
oriented problem solving 
with written materials 
individually with diabetes 
educator with behaviour 
change focus. Face to face 
and telephone. Monthly 
contacts for 24 months Vs 
Face to face education 
only with written materials.   
DD: I 28.3 [21.3] C 28.2 
[22.6] HbA1c I 7.7% [SD 
2.1] [61 mmol/ mol] C 
7.5% [SD 1.8] [58 mmol/ 
mol] 
Diabetes distress [P], HbA1c, summary of 
self-care diabetes activities; treatment self-
regulation, Diabetes  
self-efficacy; MDRTC's satisfaction sub-scale;  
Diabetes self-management competence 
Yes 
WEINGER 
2011  
USA [S10] 
RCT; PAID; 
14mths 
222 [74/75/73], males 
46-56% per group, 
mean age 52.6yrs, T1 
[50%/T2 [50%], 
Diabetes clinic, T2 
34% Insulin 
DSME: Theory based, face 
to face group education with 
goal orientation, problem 
solving, written materials 
with diabetes educator with 
BG and BCh focus. 5 x 2hr 
sessions over 6 weeks Vs 
Individual control  
DD I 34.8 [19.3] C 34.0 
[21.5]: HbA1c I 9.12% 
[SD 1.1] [76 mmol/ mol] 
C 8.9% [SD 1.1] [74 
mmol/ mol] 
HbA1c [P], self-care inventory; physical 
activity;  
24hr dietary intake; BGM; physical fitness; 
DD; Anxiety &  
Depression; diabetes-self-efficacy; coping 
styles; self-esteem; frustration with self-care 
and diabetes QOL. 
Yes 
BOND 2010  
 USA [S11] 
RCT; PAID, 
6mths 
62 [31/31], male NR, 
mean 68yrs, Type NR, 
Hospital and 
community clinics, 
Insulin NR 
DSME: Theory NR. Group & 
individual online with MDT 
online support. Unrestricted 
access with 26 weekly MDT 
sessions for 6 months with 
focus on emotions and 
behaviour change Vs Usual 
care 
DD: I 2.3 [0.88] C2.1 
[0.84] 
  
  
  
Depressive symptoms, self-efficacy, social 
support 
Primary NR 
BYRNE 2012 
AUTHOR 
REPORTED 
UK [S12] 
RCT; PAID, 
18mths 
437 [Gp size NR] 46% 
male, mean 41yrs, T1, 
hospital clinics, Insulin 
100% 
DSME: Theory NR. Group  
face to face DAFNE 
programme with a BG 
control focus delivered by 
diabetes specialists daily for 
5 days Vs Usual Care 
DD I 30 [18.9] C 29 
[18.2]: HbA1c I 8.4% [68 
mmol/ mol] C 8.3% [67 
mmol/ mol] 
  
Diabetes QOL, HbA1c, anxiety & depression 
Primary NR 
FISHER 2011  
USA [S13] 
RCT; DDS, 12 
mths 
483 [256/227], male 
53%, mean 56yrs, T2, 
Primary Care, Insulin 
0% 
DMSE; Theory NR. 
Individual face to face 
education, written materials, 
problem solving, goal 
orientation with bio-
feedback. Generalist HCP 
DD I 2.4 [0.98] C 2.25 
[0.88]; HbA1c I 8.9% [SD 
1.2] [74 mmol/ mol] C 
8.9% [SD 1.2] [74 mmol/ 
mol]  
Depression [P], diabetes distress [P], HbA1c 
No 
delivered 5 sessions over 12 
mths with an emotions focus 
Vs Enhanced usual care 
MCMAHON 
2012  
USA [S14] 
RCT; PAID; 
12mths 
152 [51/51/50], male 
95%, mean 62yrs, T2, 
Veteran's affairs org, 
Insulin NR 
DSME: Theory NR. 
Individual face to face 
session plus tele-care and 
education with biofeedback 
and medication titration with 
diabetes HCP. Bi-weekly 
phone calls duration NR. 
Blood glucose control focus 
Vs Individual online care 
with no HCP 
DD I 24.5 [20] C 29 
[19.6]: HbA1c I 9.9% [85 
mmol/ mol] C 10.1% [87 
mmol/ mol] 
HbA1c [P] & CVD outcomes 
No 
GLASGOW 
2012  
USA [S15] 
RCT; DDS; 
12mths 
463 [132/169/162], 
male 51%, mean 
58yrs, T2, Primary 
care, Insulin NR 
DSME: Theory based, 
Online education, problem 
solving, goal oriented, 
Computer-based interactive 
with health professional 
telephone support and group 
face to face sessions with 
behaviour change focus. 
Mean logins 2.6-10.45 range 
per month for 12 months Vs 
Usual care  
DD: I 3.3 [0.10] C 3.0 
[0.11]; HbA1c I 8.26% 
[SD 0.13] [67 mmol/ mol] 
C 8.16% [SD 0.16] [66 
mmol/ mol] 
Eating behaviours, estimated fat intake; 
medication adherence,  
CVD outcomes, self-efficacy, problem solving 
skills, general health  
status & HbA1c 
 
Primary NR 
GLASGOW 
2006  
USA [S16] 
RCT; DDS, 2 
mths 
335 [174/161], male 
50%, mean 62yrs, T2, 
Primary care, Insulin 
NR 
Psycho-educational: 
Theory based. Single face to 
face, individual session with 
general HCP trained in 
motivational interviewing 
techniques and goal setting 
with online education and 
bio-feedback. Focus on diet 
and physical activity vs 
Enhanced usual care 
DD: I 40.1 [17.5] C 41.5 
[18.9]; HbA1c I 7.4% [SD 
1.6] [57 mmol/ mol] C 
7.5% [SD 1.6] [58 mmol/ 
mol] 
Dietary changes, Depression, HbA1c, 
Cholesterol 
Primary NR 
HEINRICH 
2010  
NETHERLAN
D [S17] 
RCT; PAID; 
24mths 
584 [Number  
randomized NR], male 
46%, mean  59yrs, T2, 
Primary care, Insulin 
NR 
Psychological: Theory 
based .Face to face, 
individual Motivational 
Interviewing and Supportive 
Counselling with diabetes 
HCP. 8 x 20 minute sessions 
every 4 months for 2 years 
with a behavior change 
focus Vs Usual care 
DD I 14.7 [13.05] C 
16.48 [13.65]: HbA1c 
7.7% [61 mmol/ mol] < 
7.0% [<53 mmol/ mol]  
Self-management behaviors; Food 
frequency;  
Physical activity; CVD outcomes, HbA1c, 
perceived autonomy, self-efficacy, Health 
locus of control, knowledge 
Primary NR 
HERMANIDE
S 2011  
EUROPE 
WITH PI IN 
NETHERLAN
D [S18] 
RCT; PAID; 6 
mths 
83 [44/39], male 52%, 
mean age 38.4yrs, T1, 
hospital clinics, Insulin 
100% 
Drugs/Devices: Theory NR. 
Sensor augmented insulin 
pump supported by face to 
face individual sessions with 
diabetes HCP. 3 sessions in 
3 months with a blood 
glucose control focus Vs 
Multiple daily injections 
DD I 32.4 [18.8] C 26.5 
[18.4]: HbA1c I 8.5% [69 
mmol/ mol] C 8.6% [70 
mmol/ mol]  
  
HbA1c [P], hypo frequency, QOL, treatment  
satisfaction, hypo fear 
Yes 
HERMANNS 
2009  
GERMANY 
[S19] 
RCT crossover; 
PAID,  Discharge 
at 43hrs 
50 [number  
randomized NR], Male 
53%, mean 42yrs, T1, 
hospital Inpatients, 
Insulin 100% 
Drugs/Devices: Theory NR. 
Continuous Blood Glucose 
monitor [CBGM] & real time 
bio-feedback supported by 
diabetes HCP, face to face, 
individual sessions during 
single inpatient stay of 43 hrs 
with blood glucose focus Vs 
CBGM with retrospective 
bio-feedback of same 
duration 
DD 30.7: HbA1c 8.1% 
[65 mmol/ mol] 
Continuous glucose monitoring satisfaction,  
State-Trait anxiety, Depressive symptoms 
Primary NR 
HERMANNS 
2012 
GERMANY 
[S20] 
RCT; PAID; 
6mths 
186 [92/94], male 55%, 
mean age 62.9yrs, T2, 
diabetes clinics, Insulin 
100% 
DSME: Theory NR. Group 
face to face with problem 
solving, goal setting and 
written materials focusing on 
blood glucose control in 10 x 
90 min sessions Vs Didactic 
group education of same 
length/frequency 
DD: I 52.5 [9.2] C 47.6 
[9.6]; HbA1c  I 8.5% [SD 
1.5] [69 mmol/ mol] C 
8.2% [SD 1.1] [66 mmol/ 
mol] 
HbA1c [P], Knowledge, Self-care activities, 
HRQOL, Weight 
Yes 
LAMERS 
2011 
NETHERLAN
D [S21] 
RCT; PAID, 
9mths 
208 [105/103], male 
49%, mean 70yrs, T2, 
primary care, Insulin 
30% 
Psycho-educational: 
Theory based. Individual, 
face to face CBT and written 
educational components 
with a general HCP focusing 
on reducing distress and 
behavior change over 4 
sessions Vs Usual care  
DD: I 22.6 [20.5] C23.4 
[19.5]: HbA1c I 7.5% [SD 
1.2] [58 mmol/ mol] C 
7.2% [SD1.4] [55 mmol/ 
mol] 
Diabetes symptom distress, HbA1c, 
Depressive symptoms   
Primary NR 
STURT 2008  
UK [S22] 
RCT; PAID; 
6mths 
245 [114/131], Male 
60%, mean 62yrs, T2, 
primary care, Insulin 
NR 
DSME: Theory based.  
Individual, face to face and 
telephone supported 
education with written and 
audio visual materials 
delivered by general HCP 
with behavior change focus. 
Delivered in 4 x 10min 
sessions over 12 weeks vs 
Waiting list control 
DD I 21 [15] C 21 [15]; 
HbA1c I 8.9% [SD 1.4] 
[74 mmol/ mol] C 8.7% 
[SD 1.4] [72 mmol/ mol] 
  
HbA1c [P], CVD outcomes, self-efficacy 
No 
WHITTEMOR
E 2004 USA 
[S23] 
RCT; PAID; 
6mths 
53 [29/24], male 0%, 
mean 58yrs, T2, 
hospital clinic, Insulin 
NR 
Psycho-educational: 
Theory based individual face 
to face and telephone 
supported Motivational 
Interviewing and self-help 
education with nurse coach. 
7 sessions over 5 months 
with mood, distress and 
behavior change focus Vs 
Usual care 
DD I 59.9 [22] C 42.3 
[14]: HbA1c I 7.7% [SD 
1] [61 mmol/ mol] C 7.6% 
[SD 1] [60 mmol/ mol] 
HbA1c, BMI, dietary intake, Physical activity, 
integration and treatment satisfaction 
Primary NR 
HERMANNS  
[IN PRESS] 
2014 
GERMANY 
[S24] 
RCT; PAID; 
12mths 
214 [106/108], male 
43%, mean 43.3yrs, T1 
64.5%/T2 35.5%, 
hospital inpatients, 
Insulin NR 
Psycho-educational: 
Group based diabetes 
specific CBT with 
psychologist in 5 x 90 min 
sessions. Face to face and 
telephone support. Theory 
based with focus on mood 
and behavior change Vs 
Group DSME 
DD I 41.1 [19.1] C 37.9 
[17.5]; HbA1c I 8.8% [SD 
1.7] [73 mmol/ mol] C 
8.7% [SD 1.7] [72 mmol/ 
mol] 
Depression, depressive symptoms [P], 
Wellbeing, treatment satisfaction, QOL, self-
care, glycaemic control & CVD outcomes. 
YES 
WELCH 2011 
USA [S25] 
RCT; PAID, 
6mths 
234 [58/58/57/61], 
male 41%, mean 
56yrs, T2, hospital 
clinic, Insulin per group 
range 22%-46% 
Psycho-educational: 
Theory based. Individual 
motivational interviewing 
face to face with diabetes 
specialist plus DSME in 4 x 
40mins sessions over 6 
months with a behavior 
change focus Vs DSME 
DD I 41.9 [22.4] C 43.4 
[25.0]: HbA1c 8.9% [74 
mmol/ mol] 
HbA1c [P], Depression, treatment 
satisfaction,  
self-care behaviors. 
No 
 
WELCH 2011  
USA [S26]   
RCT; PAID 
Spanish version, 
12mths 
46 [21/25], male 33%, 
mean 56yrs, T2, 
community clinic, 
Insulin NR 
Disease management: 
Theory NR. Individual web-
based assessment and 
management  tool and 
DSME used by Diabetes 
HCP and patient in 7 x 1hr 
face to face sessions over 12 
months with online remote 
interaction. Focus on mood, 
distress and behavior 
change vs Attention 
control DSME 
DD I 44.3 [23] C 54.2 
[24]; HbA1c I 9.0% [75 
mmol/ mol] C 8.5% [69 
mmol/ mol] 
HbA1c, BP, eye exams, Treatment 
satisfaction, Depression 
Primary NR 
SAMUEL 
HODGE 2006 
USA [S27] 
RCT; PAID; 
12mths 
201 [117/84], male 
36%, mean 59yrs, T2, 
Churches, Insulin 29% 
Psycho-educational: 
Theory based. Motivational 
interviewing, supportive 
counselling and DSME 
provided in 25 contacts via 
individual and group face to 
face sessions and peer 
telephone support. Focus on 
Mood, distress and behavior 
change by MDT and peers 
Vs Usual care 
DD I 23 [20.4] C 22.9 
[18.6]: HbA1c I 7.77% 
[61 mmol/ mol] C 7.79% 
[62 mmol/ mol] 
HbA1c, CVD outcomes, Physical Activity, 
Food  
frequency, spirituality,  coping styles, health 
status, perceived diabetes competence, 
perceived stress, perceived barriers, social 
support, stages of  
behavior change 
Primary NR 
SPENCER 
2011  
USA [S28] 
RCT; PAID; 6 
mths 
164 [72/92], male 38%, 
mean 52.8yrs, T2, 
Community, Insulin 
27% 
Psycho-educational:  
Theory based. Group face to 
face Motivational 
Interviewing and DSME with 
HCP plus individual 
telephone lay coach support. 
11 sessions plus bi-weekly 
DD I 23.8 [22.1] C 25.9 
[22.8]: HbA1c I 8.55% 
[70 mmol/ mol] C 8.46% 
[69 mmol/ mol] 
HbA1c, CVD outcomes, knowledge, self  
management, self-efficacy, physical activity 
and  
food practices 
Primary NR 
telephone calls, 
duration/frequency NR, with 
behavior change focus Vs 
Wait list control 
KHUNTI 2012  
UK [S29] 
RCT; PAID, 
36mths 
824 [387/437], male 
55%, mean 60yrs, T2, 
primary care, Insulin 
=/<3% 
DSME: Theory based face to 
face group DESMOND 
education with problem 
solving, goal setting and 
written materials with 
diabetes HCPs. 6 hrs over 1 
or 2 sessions with 
knowledge and behavior 
change focus Vs Usual care 
DD NR; HbA1c 8.0% 
[64 mmol/ mol] 
HbA1c [P], CVD outcomes, smoking, Physical 
activity, QOL, health beliefs, depression, 
Medication use 
No 
D'ERAMO 
MELKUS 
2010 USA 
[S30] 
RCT; PAID; 24 
mths 
109 [52/57], male 0%, 
mean 46yrs, T2, 
primary care, Insulin 
0% 
Psycho-educational: 
Theory based. Face to face 
group CBT & DSME with 
written materials and self-
blood glucose monitoring 
delivered by trained general 
HCP. 11 x 90 min weekly 
sessions with distress and 
mood focus Vs Usual care 
DD I 54 [31] C 60 [30]: 
HbA1c I 8.0% [64 mmol/ 
mol] C 8.3% [67 mmol/ 
mol] 
HbA1c [P], CVD outcomes, Anxiety, social 
support,  
self-efficacy, knowledge, general QOL, health 
care provider support 
No 
GABBAY 
2013  
USA [S31] 
RCT; PAID; 
24mths 
545 [232/313],male 
42%, mean age 58yrs, 
T2, primary care, 
Insulin NR 
 
 
 
 
Psychological: Theory 
based. Individual 
motivational interviewing 
face to face sessions with 
diabetes nurse with 
telephone/email support as 
required. 8 sessions over 24 
months with empowerment 
change focus Vs Usual care 
DD I 29 [23] C 29 [24] 
HbA1c I 9.05% [75 
mmol/ mol] C 8.82% [73 
mmol/ mol] 
Depressive symptoms, diabetes quality of life,  
self-care, treatment satisfaction, HbA1c, CVD  
outcomes and screening attendance. 
Primary NR 
HERMANNS 
2013 
AUTHOR 
REPORTED  
GERMANY 
[S32] 
RCT; DDS; 
6mths 
160 [81/79], male 56%, 
mean age 45.5yrs, T1, 
Diabetes clinic, Insulin 
100% 
Psycho-educational: 
Theory based. Group face to 
face using motivational 
interviewing involving 
family/friends delivered by 
diabetes specialist. 12x 90 
DD I 1.3 [1] C 1.2 [0.9] 
HbA1c I 8.3% [67 / mol] 
C 8.0% [64 mmol/ mol] 
HbA1c [P], depressive symptoms, 
empowerment,  
self-efficacy, knowledge, self-care behavior,  
satisfaction with insulin therapy, 
hypoglycaemia awareness 
Yes 
min sessions over 6 weeks 
with a blood glucose control 
focus Vs Group education 
attention control 
 
LERMAN 
2009 
TRANSLATE
D 
MEXICO 
[S33] 
RCT; PAID; 
12mths 
70 [41/29], male mean 
across groups 
17/33/41%, mean age 
57.5yrs, T2, diabetes 
clinic, Insulin 24% 
DSME: Theory NR. 
Individual telephone 
consultations with general 
physicians in addition to 
routine face to face 
consultations. Monthly calls 
intensity NR. Behavior 
change focus Vs Usual 
care.  
DD I 45 [23] C 51 [19] 
HbA1c I 8.5% [SD 1.4] 
[69 mmol/ mol] C 9.3% 
[SD 1.9] [78 mmol/ mol] 
HbA1c, depression, adherence to treatment  
[4 questions], diabetes knowledge 
Primary NR 
QUINN 2011  
USA [S34] 
 
RCT; DDS; 
12mths 
213 [80/33/38/62]; 
male 50%, mean age 
52.9yrs, T2, Primary 
care, Insulin NR 
DSME: Theory NR. 
Individual online/ mobile 
phone based programme 
with bio-feedback and 
educational/ behavioral 
diabetes nurse coaching. 
Duration 12 month with 
ongoing intensity with 
glycaemic control focus Vs 
Usual care. 
DD I 2.4 [0.9] C 2.6 [0] 
HbA1c I 9.2% [SD 1.7] 
[77 mmol/ mol] C 9.9% 
[SD 2.1] [85 mmol/ mol] 
HbA1c [P], patient reported diabetes 
symptoms, depression, CVD outcomes 
Yes 
BEVERLY 
2013  
USA [S35] 
RCT; PAID; 
12mths 
134 [67/67], male 49&, 
mean age 59.1 [8.7], 
T2, Diabetes clinics, 
Insulin NR 
DSME: Theory based. 
Group face to face education 
with Conversation maps with 
diabetes specialist. 4 x 1 hr 
sessions with behavior 
change focus Vs Group 
didactic education 
DD I 33.3 [20.3] C 34.8 
[23.1] HbA1c I/C 8.4% 
[68 mmol/ mol] 
HbA1c [P], psychological symptoms, quality 
of life,  
self-efficacy, self-care behaviors,  frustration 
and  
barriers with diabetes self-management  
No 
DENNICK 
2014  
UK [S36] 
RCT; PAID; 
3mths 
41 [23/18], male 61%, 
mean age  65.5 [9.9], 
T2, Primary Care, 
Insulin 10% 
Psychological: Theory 
based. Individual written 
emotional disclosure with no 
HCP support. 3 x 20min 
sessions over 1 week with 
mood focus Vs Non-
DD I 37.1 [2.5] C 34.4 
[2.3] HbA1c I/C 7.0% [53 
mmol/ mol] 
Depressive symptoms [P], self-management  
behaviors, perceived health status 
No 
psychological writing 
control 
MALANDA 
2011  
AUTHOR 
REPORTED 
NETHERLAN
D [S37] 
 
RCT; PAID; 
12mths 
181 [60/59/62],  Male 
66%, mean age  61.5 
[7.8], T2, Diabetes 
clinics, Insulin 0% 
Drugs/Devices: Theory NR. 
Blood Glucose monitoring 
with education, Individual 
face to face over 2 x 30 min 
sessions with research 
assistant with a focus on 
reducing distress vs Usual 
care 
DD I 14.19 [14.7]; C 9.13 
[11.0] 
HbA1c I 7.5% [SD 0.6]; 
[58 mmol/ mol] C 7.4% 
[SD 0.6] [57 mmol/ mol] 
 DD [P], HbA1c, status of depression, patient  
treatment satisfaction, hypoglycaemia, 
physical  
activity, health status,  cost-effectiveness and  
cost-utility. 
No 
PIBERNIK-
OKANOVIC 
2011 
AUTHOR 
REPORTED 
CROATIA 
[S38] 
RCT;PAID;12mt
hs 
209 [74/66/69], T2, 
male 62.2%, mean age 
58.1,  Diabetes clinic 
and Insulin 30.1%,  
Psycho-educational: 
Theory based. Group CBT 
delivered face to face. 
Interventionist NR. 6x60-90 
min sessions over 6 weeks 
with mood focus. 
Interventionist NR vs Usual 
care 
DD I 37.63 [20.23]; C 
38.04 [18.57] 
HbA1c  I 7.4% [SD 1.3]; 
[57 mmol/ mol] C 7.1% 
[SD 1.1] [54 mmol/ mol] 
Depressive symptoms [P], HbA1c, self-
management, health related quality of life, 
biochemical markers 
 reflecting insulin resistance, inflammation 
and  
oxidative damage. 
Significance test not available 
SKINNER 
2011  
AUTHOR 
REPORTED 
AUSTRALIA 
[S39] 
RCT; PAID; 
9mths 
56 [29/27], male 54%, 
mean age  53.9 [11.3], 
T2, Insulin NR 
DSME: Theory NR. 
Individual risk assessment 
and behavior change 
counselling for 5 
complications delivered face 
to face and by telephone 
during 5 sessions over 9 
mths with blood glucose 
control focus. Interventionist 
NR.Vs Single session with 
risk info provided and no 
coaching/follow up. 
DD I 21 [16] C 14 [10] 
HbA1c I 8.8% [SD 1.1]; 
[73 mmol/ mol] C 9.0% 
[SD 0.9] [75 mmol/ mol] 
HbA1c, depressive symptoms, lipids, BP 
Primary NR 
VAN SON 
2011  
AUTHOR 
REPORTED 
RCT; PAID;6 
mths 
139 [70/69], male 50%, 
mean age 56.5yrs, T2 
70%, Diabetes clinic, 
Insulin NR 
Psycho-educational: 
Theory based. Group based 
CBT & Mindfulness 
programme delivered face to 
face by psychological 
DD I 22.1 [19.7] C 34.8 
[20.1] HbA1c I 7.5% [58 
mmol/ mol] C 7.6% [60 
mmol/ mol] 
DD [P], depressive symptoms [P], perceived  
stress [P], anxiety [P],  HbA1c, quality of life,  
dispositional mindfulness, self-esteem,  self-
care,  
BP 
 DD Diabetes Distress; T1 Type 1; T2 Type 2; RCT Randomised Controlled Trial; PAID Problem Areas in Diabetes Scale; DDS Diabetes Distress Scale; Vs Versus; 
mth/s Month/s; HbA1c Glycated haemoglobin; yrs Years; BMI Body Mass Index; HRQOL health-related Quality of Life; QOL Quality of Life; I Intervention; C Comparison; 
NR Not Reported; P Primary Outcome; CVD Cardio vascular disease; DSME Diabetes Self-Management Education; S1-S41 Reference no in supplementary online 
table 1; BP Blood Pressure. (C)BGM (Continuous) Blood Glucose Monitoring; HCP Health Care Professional; Psych Psychological; hr Hour  
 
  
  
NETHERLAN
DS [S40] 
 
specialist. 8 x 2 hr sessions 
over 20 weeks with mood 
focus Vs Wait list control 
Yes 
FISHER 2013  
USA [S41] 
RCT; DDS; 
12mths 
392 [146/150/96], male 
46%, mean 56yrs, T2, 
Primary care and 
hospital clinics, Insulin 
18%  
Psychological: Theory 
based individual problem 
solving therapy online and 
via telephone by a 
psychological HCP over 1 
face to face and 8 telephone 
sessions of 60mins over 48 
weeks with a distress focus 
Vs Attention control  
DD I 2.38 [.89] C 2.48 
[.95]: HbA1c I 7.34% 
[57mmol/ mol] C 7.45% 
[58 mmol/ mol] 
Diabetes distress [P], HbA1c, diet, exercise 
and  
medical adherence 
No 
  
Table 3. Apriori sub-group analyses for components associated with reduced Diabetes 
Distress 
 
 
 
Intervention categories & 
component  
No of 
studies/no of 
participants 
Standardised mean 
difference [SD]  
*= < 0.05 
CATEGORY 
DSME 17/2910 -0.00 [-0.08, 0.09] 
Psychological 8/1519 -0.02 [-0.15, 0.11] 
Psycho-educational 11/1551 -0.21 [-0.33, -0.09] * 
MEDIUM OF DELIVERY Content  
Face to face only 23/4310 -0.05 [-0.14, 0.04] 
Face to face + Remote 15/2086 -0.09 [-0.19, 0.00] 
Remote element [in any 
other type of intervention] 
16/2085 -0.08 [-0.16, 0.01] 
POTENTIALLY IMPORTANT COMPONENTS 
Diabetes Specialist 
interventionist 
19/3229 -0.03 [-0.12, 0.06] 
Generalist Interventionist 7/1246 -0.19 [-0.31, -0.08] * 
Use of theory 26/4333 -0.09 [-0.18, 0.01] 
Mood focus 15/2041 -0.15 [-0.29, 0.00] 
No mood focus 26/4567 -0.01 [-0.08, 0.05] 
≤ 5 sessions 18/2923 -0.02 [-0.14, 0.09] 
≥ 6 sessions 15/2322 -0.14 [-0.26, -0.03] * 
Duration ≤12 weeks 17/2273  0.01 [-0.13, 0.11] 
Duration ≥ 13 weeks 13/2676 -0.14 [-0.24, -0.03] * 
Motivational Interviewing 
with/without education 
11/1985 -0.09 [-0.18, -0.00] * 
Supportive Counselling  9/ 1312 -0.12 [-0.27, 0.03] 
Group format 13/2375 -0.08 [-0.22, 0.06] 
Individual [1:1] format 27/4178 -0.04 [-0.12, 0.04] 
 
no Number; DSME Diabetes self-management education; + plus; SD Standard deviation; sig 
Significant 
 
 
 
